Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Komal S Rathi

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Journal of the National Cancer Institute|February 26, 2020
Mitochondrial DNA Haplogroups and Susceptibility to NeuroblastomaXiao Chang, Marina Bakay, Yichuan Liu, et al.
Neoplasia (New York, N.Y.)|April 28, 2020
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinaseDongdong Chen, Julie Cox, Jayabhargav Annam, et al.
Molecular Oncology|February 1, 2021
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic targetCara E Shields, Sindhu Potlapalli, Selma M Cuya-Smith, et al.
BMC Bioinformatics|December 15, 2020
annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusionsKrutika S Gaonkar, Federico Marini, Komal S Rathi, et al.
Cancer Research Communications|November 16, 2022
Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastomaKateryna Krytska, Colleen E Casey, Jennifer Pogoriler, et al.
Molecular Cancer Therapeutics|May 11, 2019
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical ModelsMehran Makvandi, Hwan Lee, Laura N Puentes, et al.
NPJ Precision Oncology|November 11, 2025
Role of repulsive guidance signaling and GPR180 in pediatric low-grade glioma infiltrationGeena Jung, Zizhuo Liang, Payal Jain, et al.
Nature|October 17, 2019
The ADP/ATP translocase drives mitophagy independent of nucleotide exchangeAtsushi Hoshino, Wei-Jia Wang, Shogo Wada, et al.
Genome Research|August 16, 2020
Somatic structural variation targets neurodevelopmental genes and identifies <i>SHANK2</i> as a tumor suppressor in neuroblastomaGonzalo Lopez, Karina L Conkrite, Miriam Doepner, et al.
Genome Medicine|May 29, 2019
Clinical utility of custom-designed NGS panel testing in pediatric tumorsLea F Surrey, Suzanne P MacFarland, Fengqi Chang, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of the National Cancer Institute|February 26, 2020
Mitochondrial DNA Haplogroups and Susceptibility to NeuroblastomaXiao Chang, Marina Bakay, Yichuan Liu, et al.
Neoplasia (New York, N.Y.)|April 28, 2020
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinaseDongdong Chen, Julie Cox, Jayabhargav Annam, et al.
Molecular Oncology|February 1, 2021
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic targetCara E Shields, Sindhu Potlapalli, Selma M Cuya-Smith, et al.
BMC Bioinformatics|December 15, 2020
annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusionsKrutika S Gaonkar, Federico Marini, Komal S Rathi, et al.
Cancer Research Communications|November 16, 2022
Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastomaKateryna Krytska, Colleen E Casey, Jennifer Pogoriler, et al.
Molecular Cancer Therapeutics|May 11, 2019
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical ModelsMehran Makvandi, Hwan Lee, Laura N Puentes, et al.
NPJ Precision Oncology|November 11, 2025
Role of repulsive guidance signaling and GPR180 in pediatric low-grade glioma infiltrationGeena Jung, Zizhuo Liang, Payal Jain, et al.
Nature|October 17, 2019
The ADP/ATP translocase drives mitophagy independent of nucleotide exchangeAtsushi Hoshino, Wei-Jia Wang, Shogo Wada, et al.
Genome Research|August 16, 2020
Somatic structural variation targets neurodevelopmental genes and identifies <i>SHANK2</i> as a tumor suppressor in neuroblastomaGonzalo Lopez, Karina L Conkrite, Miriam Doepner, et al.
Genome Medicine|May 29, 2019
Clinical utility of custom-designed NGS panel testing in pediatric tumorsLea F Surrey, Suzanne P MacFarland, Fengqi Chang, et al.
Pageof 4